Home

A report of the study, which was conducted with obese mice, appears online today in the Journal of Clinical Investigation. "This is a promising early step toward a treatment for some of the serious health consequences of obesity," says Kenneth R. Warren, Ph.D., acting director of the National ...

Mexico City government worker Agueda Galvan started stretching exercises out of fear of a heart attack, but also under an anti-obesity program introduced by her bosses. The pilot plan, which began in the city's finance ministry two weeks ago, is set to expand to all of the capital's ministries in a country with an expanding obesity problem. "A ...

CHICAGO (Reuters) - A compound similar to Sanofi-Aventis' once-promising weight loss drug Acomplia helped obese mice lose weight and lower their blood fats and blood sugar without causing psychological side effects, U.S. researchers said on Monday. Like Acomplia, the drug targets cannabinoid receptors that become active after smoking marijuana, but the team tinkered with the compound to keep it from ...

PepsiCo Inc. spent $1.2 million in the second quarter to lobby the federal government on childhood obesity, climate change and other matters, according to a recent disclosure report. That's well below the $2.5 million it spent in the year-ago period and the $3 ...

Asked by the US military for tips to help combat the growing problem of obesity in the ranks, a popular television fitness guru came up with an unusual answer: mind-soothing and body-bending yoga. "I know inclusion of yoga in military training sounds a tad alien," Tony Horton, 52, acknowledged as he presented his techniques to a group of 200 people ...

NEW YORK (Reuters Health) - Some obese adults may be at increased risk of having their breathing difficulties misdiagnosed as asthma, a new study suggests. Researchers found that among nearly 500 Canadian adults who said a doctor had diagnosed them with asthma, objective lung-function testing ruled out the lung disease in 150, or 30 percent. When the investigators looked at risk ...

A panel of experts advising the US Food and Drug Administration voted Thursday against approving for sale a new obesity treatment called Qnexa, citing safety risks. The FDA is not required to follow the recommendation of the expert panel on endocrinological and metabolic drugs, but generally accepts its findings. Qnexa, made by California-based biotech firm Vivus, is the first ...

WASHINGTON (Reuters) - The first potential U.S. prescription weight-loss pill in more than a decade could move closer to market on Thursday if it can overcome safety hurdles that have plagued diet drugs for years and led to tepid sales despite the growing number of obese Americans. Vivus Inc is seeking Food and Drug Administration support to sell its drug ...

NEW YORK (Reuters Health) - If you're trying to lose weight and keep it off, new research suggests you take up a diet and exercise plan that will help you lose a big chunk of weight right off the bat. Some doctors and dieticians think that losing lots of weight fairly quickly makes it more likely that dieters will gain ...

WASHINGTON (Reuters) - Older women hoping to keep their minds young should keep an eye on the scale -- researchers have found a link between slowing down mentally and piling on the pounds/(kilos). For every extra point gained on a scale of obesity, scores in reasoning, memory and other mental skills fell, Dr. Diana Kerwin of Northwestern University in Chicago and ...